scispace - formally typeset
J

James Dooley

Researcher at Katholieke Universiteit Leuven

Publications -  92
Citations -  6688

James Dooley is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Immune system & Cellular differentiation. The author has an hindex of 34, co-authored 81 publications receiving 5924 citations. Previous affiliations of James Dooley include Allen Institute for Brain Science & University of Washington.

Papers
More filters
Journal ArticleDOI

Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3

TL;DR: Analysis of Foxp3 expression during thymic development suggests that this mechanism is not hard-wired but is dependent on TCR/MHC ligand interactions, and it is shown that expression ofFoxp3 is highly restricted to the subset alphabeta of T cells and, irrespective of CD25 expression, correlates with suppressor activity.
Journal ArticleDOI

Developmental regulation of Foxp3 expression during ontogeny

TL;DR: It is demonstrated that the development of Foxp3-expressing T reg cells is substantially delayed relative to nonregulatory thymocytes during ontogeny, and it is speculated that induction ofFoxp3 in developingThymocytes and, thus, commitment to the T reg cell lineage is facilitated by a signal largely associated with the thymic medulla.
Journal ArticleDOI

The cellular composition of the human immune system is shaped by age and cohabitation

TL;DR: A high level of interindividual variation, with low longitudinal variation, at the level of cellular subset composition of the immune system, and local environmental conditions as a key factor in shaping the human immune system are identified.
Journal ArticleDOI

Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation

TL;DR: In this paper, a family with a dominantly inherited autoinflammatory disease, distinct from FMF, characterized by childhood-onset recurrent episodes of neutrophilic dermatosis, fever, elevated acute-phase reactants, arthralgia, and myalgia/myositis, was caused by a mutation in MEFV, the gene encoding pyrin (S242R).